Clinical Trial Update: Nivolumab and All-trans Retinoic Acid for Pancreatic Cancer [EARLY_Phase 1]

View source ↗

Summary

This is an early-phase 1 clinical trial update for pancreatic cancer evaluating nivolumab plus all-trans retinoic acid. The trial is currently active but not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)
• nivolumab (nivolumab)

Snippet

Sponsor: China Medical University Hospital | Conditions: Effect of Drug | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING